Business News

Business

Regeneron and Fujifilm Forge a $3 Billion Alliance to Revolutionize US Biologic Medicine Production

Regeneron Pharmaceuticals Inc. and Fujifilm Diosynth Biotechnologies have signed a $3 billion deal to produce biologic medicines in North Carolina, marking a significant investment...

Business

EU Set to Impose Hefty Fines on Meta and Apple Over Digital Markets Act Violations

The European Commission is set to impose its first Digital Markets Act penalties on Apple and Meta, accusing them of restricting competition and data sharing practices. Fines could...

Business

Boeing Strikes a Massive $10.5B Deal with Thoma Bravo, Selling Digital Aviation Solutions

Boeing announces a $10.55 billion deal with Thoma Bravo for the sale of its Digital Aviation Solutions, retaining core digital capabilities for maintenance and diagnostics services...

Business

Chevron CEO Optimistic: U.S. Economy Shows No Immediate Signs of Recession Despite Trade Tensions

Chevron CEO Michael Wirth expresses confidence in the U.S. economy's resilience, citing no immediate recession risks despite tariff-induced uncertainties. The IMF, however, has low...

Business

Elliott Challenges BP to Dramatically Increase Cash Flow Amid Takeover Rumors

Elliott Investment Management is pressuring BP to boost its free cash flow by 40%, criticizing the current strategy as inadequate. With BP's underperformance, Elliott's increased s...

Business

British Steel Reverses Decision: Furnaces to Remain Open, Saving 2,700 Jobs Amid Government Intervention

British Steel Ltd. reverses its decision to close two blast furnaces in Scunthorpe, UK, saving 2,700 jobs after UK government intervention. The company has secured raw materials to...

Business

Boeing Strikes $10.55 Billion Deal with Thoma Bravo for Digital Aviation Assets Sale

Boeing announces a $10.55 billion sale of its digital aviation assets to Thoma Bravo, including Jeppesen, to streamline operations and strengthen financials, ensuring smooth transi...

Business

Novo Nordisk Shares Plummet 8% Following Eli Lilly's Breakthrough in Weight Loss Drug Trial

Novo Nordisk shares fell 8% after Eli Lilly reported positive trial results for its weight loss drug, orforglipron, affecting the healthcare sector. Novo Nordisk's shares dropped t...